Exviera (dasabuvir) / AbbVie  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

23 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Exviera (dasabuvir) / AbbVie
GEHEP, NCT02333292: Efficacy and Safety of Therapy Against HCV Based on Direct-acting Antivirals in Real-life Conditions

Completed
N/A
1128
Europe
Telaprevir, TVR, Boceprevir, BOC, Sofosbuvir, SOF, Simeprevir, SMV, Daclatasvir, DCV, Ledipasvir, LDV, ritonavir-boosted Paritaprevir/ Ombitasvir, PTV/OTV, Dasabuvir, DBV, Velpatasvir, VPV, Elbasvir, EBV, Grazoprevir, GZR
Valme University Hospital, Hospital del SAS de Jerez, Hospital General Universitario Elche, Hospital La Línea de la Concepción, Complexo Hospitalario Universitario de A Coruña, Hospital de Figueres, Hospital Universitario Puerto Real, Hospital Universitario Virgen de la Victoria, Hospital Universitario de Canarias, Hospital General Universitario de Alicante, Hospital Universitario Araba, Hospital Royo Vilanova, Hospital Universitario de Burgos, Complejo Hospitalario Universitario de Huelva, Hospital Universitario Reina Sofia de Cordoba, Hospital Universitario Virgen Macarena, Complejo Hospitalario Universitario de Vigo, Clinica Universidad de Navarra, Universidad de Navarra, Hospital Clinico Universitario San Cecilio, Hospital Universitario La Fe, Hospital General Universitario de Valencia, Hospital Universitario Infanta Leonor, Hospital Universitario de Gran Canaria, Hospital General Universitario Santa Lucía, Centro Penitenciario Alicante 1, Hospital Regional Universitario Carlos Haya, Hospital Virgen de la Luz, Hospital General Universitario de Castellón, Hospital Parc Taulí, Sabadell
Chronic Hepatitis C Infection
12/16
06/17
REAL, NCT02582658: Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Austria

Completed
N/A
173
NA
AbbVie
Chronic Hepatitis C
01/17
01/17
NCT02640547: Real World Evidence of the Effectiveness of Paritaprevir/Ritonavir, Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C

Completed
N/A
394
NA
AbbVie, IST GmbH, Germany
Chronic Hepatitis C
03/17
03/17
NCT02798315: Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study

Completed
N/A
40
NA
AbbVie
Chronic Hepatitis C
06/17
06/17
NCT02758509: Impact of Antiviral Therapy on Gastroesophageal Varices.

Completed
N/A
237
NA
Pegylated interferon alfa-2a + Ribavirin, Pegylated interferon alfa-2a + Ribavirin + Boceprevir, Pegylated interferon alfa-2a + Ribavirin +Telaprevir, Ledipasvir/Sofosbuvir, Ombitasvir/paritaprevir/ritonavir+Dasabuvir, Daclatasvir+Sofosbuvir, Simeprevir+Sofosbuvir
Parc de Salut Mar
Chronic Hepatitis C, Cirrhosis
06/17
10/17
HCV RWE, NCT02669940: Observational, Multi-Center Study of the Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in the Russian Federation

Completed
N/A
158
NA
AbbVie
Chronic Hepatitis C, Genotype 1
07/17
07/17
NCT02807402: Effectiveness of Paritaprevir/Ritonavir, Ombitasvir, + Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in Romania

Completed
N/A
522
NA
AbbVie, IST GmbH, Germany
Chronic Hepatitis C
08/17
08/17
NCT02725866: Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Participants With Chronic Hepatitis C

Completed
N/A
216
NA
Paritaprevir/ritonavir/ombitasvir, Paritaprevir also known as ABT-450, Ombitasvir also known as ABT-267, Dasabuvir, ABT-333, Ribavirin
AbbVie
Chronic Hepatitis C
10/17
10/17
NCT02582671: The Effectiveness of ABT-450/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C -An Observational Study in Ireland

Completed
N/A
101
NA
Ombitasvir/paritaprevir/ritonavir, Ombitasvir also known as ABT-267, Paritaprevir also known as ABT-450, Dasabuvir, ABT-333, Ribavirin
AbbVie
Chronic Hepatitis C
11/17
11/17
CITRIN, NCT03053180: Real World Evidence of the Effectiveness of Paritaprevir/Ritonavir (r) - Ombitasvir, + Dasabuvir Without Ribavirin in Participants With Chronic Hepatitis C and Compensated Liver Cirrhosis in the Russian Federation

Completed
N/A
60
RoW
AbbVie
Chronic Hepatitis C
12/17
12/17
AMBER, NCT02581189: Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in Canada

Completed
N/A
565
NA
Ombitasvir/paritaprevir/ritonavir, Ombitasvir also known as ABT-267, Paritaprevir also known as ABT-450, Dasabuvir, ABT-333, Ribavirin
AbbVie, IST GmbH, Germany, Cato Research
Chronic Hepatitis C
12/17
12/17
NCT03122132: Effectiveness, Safety and Clinical Outcomes of Paritaprevir/Ombitasvir/r+Dasabuvir 8 Weeks

Completed
N/A
200
Europe
ombitasvir/paritaprevir/ritonavir 8 weeks, viekirax, dasabuvir 8 weeks, exviera
Hepa C
Hepatitis C Infection
01/18
03/18
NCT02581163: Effectiveness of Paritaprevir/Ritonavir - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Belgium

Completed
N/A
314
NA
Ombitasvir/paritaprevir/ritonavir, Ombitasvir also known as ABT-267, Paritaprevir also known as ABT-450, Dasabuvir, ABT-333, Ribavirin
AbbVie, IST GmbH, Germany
Chronic Hepatitis C, Genotype 1 or 4
02/18
02/18
3DUTCH, NCT02817594: Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin and Patient Support Program in Patients With Chronic Hepatitis C

Completed
N/A
51
Europe
AbbVie
Chronic Hepatitis C
03/18
03/18
LIFE-C, NCT02615145: Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Germany

Completed
N/A
472
NA
AbbVie
Chronic Hepatitis C
03/18
03/18
OPALE, NCT02618928: The Effectiveness of Paritaprevir/Ritonavir - Ombitasvir, ± Dasabuvir, ± Ribavirin in France

Completed
N/A
735
Europe
AbbVie
Chronic Hepatitis C
03/18
03/18
HEMATITE, NCT03002818: Quality of Life Measurement in Treatment Naïve Patients With Hepatitis C Virus (HCV) Genotype 1 (GT1) Suffering From Fatigue and Receiving Ombitasvir, Paritaprevir, and Ritonavir and Dasabuvir (Viekirax®/Exviera®)

Completed
N/A
41
Europe
AbbVie
Chronic Hepatitis C Virus (HCV)
04/18
04/18
VERITAS, NCT02636608: Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Hungary

Completed
N/A
244
NA
AbbVie, IST GmbH, Germany
Chronic Hepatitis C
05/18
05/18
NCT02851069: Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in Colombia

Completed
N/A
66
RoW
AbbVie
Chronic Hepatitis C
08/18
08/18
CITRINE, NCT02803138: Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin and Patient Support Program in Patients With Chronic Hepatitis C

Completed
N/A
256
RoW
Ombitasvir/paritaprevir/ritonavir, Ombitasvir also known as ABT-267, Paritaprevir also known as ABT-450, Dasabuvir, ABT-333, Ribavirin, Patient support program
AbbVie
Chronic Hepatitis C
10/18
10/18
NCT04047680: eGFR Evolution in HCV Patients Receiving SOF-based or SOF-free DAAs

Completed
N/A
441
RoW
Sofosbuvir / Velpatasvir Oral Tablet, Epclusa, Sofosbuvir and Ledipasvir, Harvoni, Sofosbuvir Tablets, Solvadi, Ombitasvir/paritaprevir/ritonavir, Viekirax/exviera, Elbasvir / Grazoprevir Oral Tablet, Zepatier, Glecaprevir and Pibrentasvir, Maviret
National Taiwan University Hospital
Hepatitis C, Renal Disease, Viral Hepatitis C
12/18
06/19
HCV PMS, NCT03201718: A Study of Viekira/Exviera for Korean Hepatitis C Patients According to the Standard for Re-examination of New Drugs

Completed
N/A
505
RoW
AbbVie
Hepatitis C Virus (HCV)
10/19
10/19
NCT02057003: Real-life Security and Efficacy of DAA-based Therapy in HCV/HIV-Coinfected Patients

Unknown status
N/A
1000
Europe
DAA against HCV, telaprevir, boceprevir, simeprevir, sofosbuvir, daclatasvir, ombitasvir, paritaprevir, dasabuvir, ledipasvir, grazoprevir, elbasvir, velpatasvir
Valme University Hospital, Hospital Universitario Reina Sofia de Cordoba, Hospital Universitario Virgen de la Victoria, Fundación de Investigación Biomédica - Hospital Universitario de La Princesa, Hospital Regional de Malaga, Hospital Torrecárdenas, Complejo Hospitalario Universitario de Huelva, Hospital Universitario Puerta del Mar, Hospital Universitario Virgen Macarena, Hospital La Línea, Complejo Hospitalario de Jaén, Hospital Universitario Puerto Real, Hospital Universitario de Canarias, Hospital Poniente, Hospital Universitario Central de Asturias, Hospital Álvaro Cunqueiro, Hospital Universitario Virgen de la Arrixaca, Hospital Universitario de Gran Canaria
Hepatitis C, Chronic, Human Immunodeficiency Virus
12/20
12/20

Download Options